Stay updated on PD1-LAG3 Bispecific Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page.

Latest updates to the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page
- Check5 days agoChange DetectedThe study history now shows that recruitment has ended, reflecting no longer looking for participants; the record history also updates to version v3.6.0 (replacing v3.5.5).SummaryDifference0.2%

- Check12 days agoChange DetectedA new revision entry (v3.5.5) was added to the page's history and the prior revision (v3.5.4) was removed, reflecting a small update in the page's version history.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page's revision label updated from v3.5.3 to v3.5.4, indicating an administrative software update to the site. This does not reflect changes to the trial data or core content.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page now shows a newer UI/build revision identifier (“Revision: v3.5.3”) instead of the previous one (“Revision: v3.5.2”). This indicates a platform/version update rather than a change to the trial’s published content.SummaryDifference0.0%

- Check62 days agoChange DetectedA new revision v3.5.2 was added to the history, replacing the previous revision v3.5.0.SummaryDifference0.0%

- Check91 days agoChange DetectedNew Study Status information was added to the history, with a revision note for v3.5.0 dated 2026-03-18.SummaryDifference0.2%

Stay in the know with updates to PD1-LAG3 Bispecific Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page.